Probo Medical Acquires SonoDepot

April 19, 2021

Probo Medical is a leading global provider of medical imaging equipment, parts, repair and service. Terms of the transaction were not disclosed.

Probo Medical notes SonoDepot, founded in 1985, is a St. Cloud, Florida-based third-party service, maintenance, and repair organization with deep specialization in ultrasound equipment. SonoDepot’s team of field service engineers have a long history of supporting hospitals, physician offices and imaging centers across the United States for their ultrasound maintenance, service and sales needs. SonoDepot, led today by Floyd McAuliffe and Jack McAuliffe, also offers ultrasound equipment leasing solutions to its customers.

“We are excited to welcome the SonoDepot team to Probo Medical,” said Michael Asmer, CEO of Probo Medical. “With their deep technical expertise across OEM models, the SonoDepot team has established themselves as one of the premier service and repair businesses in the ultrasound sector. Adding the SonoDepot field service engineers to Probo’s existing service footprint extends Probo as a coast-to-coast third-party service provider and we’re excited to support SonoDepot’s customers with the added-resources of Probo.”

SonoDepot President, Floyd McAuliffe, said, “Partnering with Probo provides SonoDepot with a proven platform and management team that will allow the business to continue to thrive into the future. With Probo’s vast inventory of ultrasound parts, probes and systems, we are excited for the positive impacts this will have on our ability to exceed our customers’ expectations. We would like to express our gratitude to the thousands of sonographers that we’ve had the joy of serving for nearly 40 years, and to our employees that have taken SonoDepot to this level.”

Jack McAuliffe, SonoDepot CEO, added, “We have known the Probo team for many years and see deep alignment, not only with respect to our business interests, but, more importantly, in a common culture that puts the customer and our employees at the center of what we do. We feel very fortunate to serve our customers and to have built the strong relationships we have with our customers over the many years of supporting their ultrasound needs. Our team is enthusiastic to continue that as part of the Probo family.”

Probo Medical is backed by Varsity Healthcare Partners, a lower middle-market private equity investment firm focused on partnering with founders, entrepreneurs and management teams to build leading healthcare services companies.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.